Thorne HealthTech Target Price vs. Current Ratio

THRNDelisted Stock  USD 6.40  0.48  8.11%   
Considering the key profitability indicators obtained from Thorne HealthTech's historical financial statements, Thorne HealthTech may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Thorne HealthTech's ability to earn profits and add value for shareholders.
For Thorne HealthTech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Thorne HealthTech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Thorne HealthTech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Thorne HealthTech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Thorne HealthTech over time as well as its relative position and ranking within its peers.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Please note, there is a significant difference between Thorne HealthTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thorne HealthTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thorne HealthTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Thorne HealthTech Current Ratio vs. Target Price Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Thorne HealthTech's current stock value. Our valuation model uses many indicators to compare Thorne HealthTech value to that of its competitors to determine the firm's financial worth.
Thorne HealthTech is rated below average in target price category among its peers. It is rated below average in current ratio category among its peers fabricating about  0.42  of Current Ratio per Target Price. The ratio of Target Price to Current Ratio for Thorne HealthTech is roughly  2.37 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Thorne HealthTech's earnings, one of the primary drivers of an investment's value.

Thorne Current Ratio vs. Target Price

Thorne HealthTech

 = 
6.9
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Thorne HealthTech

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
2.91 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).

Thorne Current Ratio Comparison

Thorne HealthTech is currently under evaluation in current ratio category among its peers.

Thorne HealthTech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Thorne HealthTech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Thorne HealthTech will eventually generate negative long term returns. The profitability progress is the general direction of Thorne HealthTech's change in net profit over the period of time. It can combine multiple indicators of Thorne HealthTech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York. Thorne Healthtech operates under Packaged Foods classification in the United States and is traded on NASDAQ Exchange. It employs 496 people.

Thorne Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Thorne HealthTech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Thorne HealthTech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Thorne HealthTech's important profitability drivers and their relationship over time.

Use Thorne HealthTech in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Thorne HealthTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thorne HealthTech will appreciate offsetting losses from the drop in the long position's value.

Thorne HealthTech Pair Trading

Thorne HealthTech Pair Trading Analysis

The ability to find closely correlated positions to Thorne HealthTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Thorne HealthTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Thorne HealthTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Thorne HealthTech to buy it.
The correlation of Thorne HealthTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Thorne HealthTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Thorne HealthTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Thorne HealthTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Thorne HealthTech position

In addition to having Thorne HealthTech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Latest Losers Thematic Idea Now

Latest Losers
Latest Losers Theme
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Losers theme has 105 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Losers Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in Thorne Stock

If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges